Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
07/2003
07/10/2003US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
07/10/2003US20030130271 1,3-Diheterocyclic metalloprotease inhibitors
07/10/2003US20030130254 Respiratory system disorders; antihistamines; antiarthritic agents
07/10/2003US20030130239 Vision defects
07/10/2003US20030130209 Method of treatment of myocardial infarction
07/10/2003US20030130168 Reverse-turn mimetics and methods relating thereto
07/10/2003US20030129251 Polynucleotide of an immunostimulatory sequence linked to a biodegradable microcarrier
07/10/2003US20030129182 Contacting vitreous humor with beta-glucuronidase, matrix metalloproteinase, chondroitinase, chondroitin sulfatase, and/or protein kinase; thimerosal-free
07/10/2003CA2482392A1 Carboxylic acid derivative
07/10/2003CA2471306A1 Secreted proteins
07/10/2003CA2470666A1 Secreted protein
07/10/2003CA2463143A1 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
07/09/2003EP1325932A2 Anti-vegf antibodies
07/09/2003EP1325904A1 Novel aliphatic compounds, process for their preparation and their usage
07/09/2003EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage
07/09/2003EP1325745A1 Preventives and remedies for complications of diabetes
07/09/2003EP1325744A1 Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof
07/09/2003EP1325117A2 Lipid metabolism enzymes
07/09/2003EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof
07/09/2003EP1325010A1 Substituted 3.4-dihydro-pyrimido 1,2-a]pyrimidines and 3.4-dihydropyrazino 1,2-a]pyrimidines
07/09/2003EP1325007A2 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
07/09/2003EP1324995A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
07/09/2003EP1324994A2 Tricyclic compounds and uses thereof
07/09/2003EP1324991A1 Compounds useful in the treatment of inflammatory diseases
07/09/2003EP1324990A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
07/09/2003EP1324985A1 Inhibitors of prenyl-protein transferase
07/09/2003EP1324782A2 Stabilized hydrogen peroxide solutions
07/09/2003EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition
07/09/2003EP1324767A2 Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery
07/09/2003EP1324748A1 Topical antibiotic composition for treatment of eye infection
07/09/2003EP0948500B1 Cyclic organoselenium compounds, their preparation and their uses
07/09/2003EP0901483B1 Benzofurans and benzopyrans as chronobiological agents
07/09/2003EP0823906B1 Piperazino derivatives as neurokinin antagonists
07/09/2003CN1429222A 激酶抑制剂 Kinase inhibitors
07/09/2003CN1429209A Disulfide derivatives useful for treating allergic diseases
07/09/2003CN1429208A Aniline disulfide derivatives for treating allergic diseases
07/09/2003CN1429200A Anthranyl amides and their use as medicaments
07/09/2003CN1429112A Composition for use in treatment of ocular hypertension and glaucoma
07/09/2003CN1429110A Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
07/09/2003CN1428145A Quinoline derivative as tachykinin NK3 receptor agonist
07/08/2003US6589978 Therapy for nervous system disorders
07/08/2003US6589972 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects
07/08/2003US6589954 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful
07/08/2003US6589951 Phthalazine derivatives as phosphodiesterase 4 inhibitors
07/08/2003US6589286 Eustachian tube stent
07/08/2003CA2272640C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
07/08/2003CA2271841C 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
07/08/2003CA2254682C Method of treating eye infections with azithromycin
07/03/2003WO2003054012A2 Leptin proteins
07/03/2003WO2003053975A1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
07/03/2003WO2003053969A1 Imidazoquinoline derivatives
07/03/2003WO2003053967A1 Aroyl pyridinones
07/03/2003WO2003053966A2 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists
07/03/2003WO2003053957A1 Benzhydryl derivatives
07/03/2003WO2003053923A2 Pyrrolidine derivatives as prostaglandin modulators
07/03/2003WO2003053915A2 Compounds for the treatment of inflammatory disorders
07/03/2003WO2003053480A1 Composition for treating contact lenses in the eye
07/03/2003WO2003053472A1 Eye drops
07/03/2003WO2003053452A1 Heparin-containing ophthalmic agent
07/03/2003WO2003053437A1 Triazoles as oxytocin antagonists
07/03/2003WO2003053436A1 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
07/03/2003WO2003053405A1 Method and composition for dry eye treatment
07/03/2003WO2003053368A2 Chalcone derivatives and their use to treat diseases
07/03/2003WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
07/03/2003WO2003053361A2 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
07/03/2003WO2003053346A2 Systems and methods for treating patients with processed lipoaspirate cells
07/03/2003WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003WO2002076497A3 Method and composition
07/03/2003WO2002018389A3 Thienopyrimidine
07/03/2003US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder
07/03/2003US20030125523 Novel neuropilin/growth factor complexes and uses thereof
07/03/2003US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor
07/03/2003US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis
07/03/2003US20030125351 Administering a heterocyclic amide compound to a glaucoma patient for inhibiting contraction of ciliary muscle; Rho kinase inhibitor
07/03/2003US20030125344 Rho-kinase inhibitors
07/03/2003US20030125339 Substituted alkylamine derivatives and methods of use
07/03/2003US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
07/03/2003US20030125299 Method for treating or preventing inflammatory diseases
07/03/2003US20030125294 Selective toxin expression in angiogenic endothelial cells
07/03/2003US20030125293 Cell culture product for the treatment and repair of eye vision defects
07/03/2003US20030125259 Administering to the mammal a therapeutically acceptable amount of a octa or nonapeptide compound to inhibit the angiogenesis
07/03/2003US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein
07/03/2003US20030125221 Method and composition for cleaning and disinfecting contact lenses
07/03/2003US20030124617 Antiinflammatory agents; antiarthritic agents; interleukins; antiallergens; bronchodilator agents
07/03/2003US20030124150 Kit for reducing aching
07/03/2003US20030124129 Angiopoietin-2 specific binding agents
07/03/2003US20030124116 Antibodies binding to polypeptides encoded by the genes
07/03/2003CA2849201A1 Adipose-derived cell processing unit
07/03/2003CA2471085A1 Aroyl pyridinones
07/03/2003CA2471083A1 Benzhydryl derivatives
07/03/2003CA2470931A1 Chalcone derivatives and their use to treat diseases
07/03/2003CA2470594A1 Leptin proteins
07/03/2003CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003CA2470003A1 Composition for treating contact lenses in the eye
07/03/2003CA2469904A1 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
07/03/2003CA2469370A1 Adipose-derived cell processing unit
07/03/2003CA2469042A1 Triazoles as oxytocin antagonists
07/03/2003CA2468775A1 Heparin-containing ophthalmic agent
07/02/2003EP1323824A2 Use of human keratinocyte growth factor-2 for the preparation of pharmaceutical compositions
07/02/2003EP1323426A1 Eye drops
1 ... 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 ... 531